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Background
Osteoclasts (OCLs) are bone resorbing cells derived
from the monocyte lineage (MN-OCLs) in steady state
special. We have shown that in vivo, dendritic cells can
differentiate into OCLs (DC-OCLs) and this mechanism
requires the presence of inflammatory CD4+ T cells.
Recent studies have suggested that MN-OCLs could
modulate T cells. Our aim was to better characterize
the effect of OCLs on T cells and in particular to com-
pare both OCL subsets (DC-OCLs and MN-OCLs) in
terms of antigen presentation and T cell activation.
Material and methods
DC-OCLs and MN-OCLs were generated in vitro from
murine bone marrow. After purification, their phenotype
and effect on T cells were analyzed in coculture in an
antigen-specific system.
Results
Our results revealed that both OCL subsets express
similarly the molecules involved in antigen presentation
and costimulation. Both OCL subsets process and pre-
sent antigens identically, without the need to resorb.
Transcriptomic analyses showed that MN-OCLs express
higher levels of immunosuppressive cytokines whereas
DC-OCLs express higher levels of inflammatory cyto-
kines. Their effect on T cells was evaluated in coculture
of DC-OCLs or MN-OCLs with CD4+ T cells from
OTII mice (ovalbumin-specific TCR) in the presence or
not of ovalbumine. Using CFSE staining, we found that
DC-OCLs induce T cell proliferation more efficiently
than MN-OCLs. Intracytoplasmic analysis of cytokine
production revealed that DC-OCLs induce efficiently a
Th1 polarization whereas MN-OCLs induce regulatory
T cells.
Conclusion
Our results demonstrate that OCLs may have an immu-
nomodulatory function. cells. The immunosuppressive
effect of MN-OCLs may maintain a tolerance against
self-antigens produced during bone resorption. The
immunogenic capacity of DC-OCLs may participate to
the vicious circle linking bone destruction to chronic
inflammation. This mechanism represents a very novel
concept in the regulation of the balance between immu-
nosuppression and inflammation.
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